Blurbs

Raymond James Remains a Buy on Addus Homecare (ADUS)

In a report released today, John Ransom from Raymond James maintained a Buy rating on Addus Homecare (ADUSResearch Report), with a price target of $125.00. The company’s shares closed yesterday at $108.58.

Ransom covers the Healthcare sector, focusing on stocks such as HCA Healthcare, Encompass Health, and UnitedHealth. According to TipRanks, Ransom has an average return of 9.7% and a 59.26% success rate on recommended stocks.

Addus Homecare has an analyst consensus of Strong Buy, with a price target consensus of $120.00, a 10.52% upside from current levels. In a report released today, RBC Capital also maintained a Buy rating on the stock with a $121.00 price target.

See today’s best-performing stocks on TipRanks >>

The company has a one-year high of $112.11 and a one-year low of $68.57. Currently, Addus Homecare has an average volume of 102.8K.

Based on the recent corporate insider activity of 54 insiders, corporate insider sentiment is neutral on the stock. Most recently, in August 2022, GAFFNEY SEAN, the EVP of ADUS sold 10,000.00 shares for a total of $950,000.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as for their families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after surgery, and include skilled nursing and physical, occupational and speech therapy. The company was founded on July 27, 2006 and is headquartered in Frisco, TX.

Read More on ADUS:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More